LOGIN 
Price management solution optimized to reduce manual processing
GPI and Model N address key challenges for pricing and launch excellence for a global pharmaceutical company.
April 21, 2022
Strategies to mitigate global price and revenue erosion within hemophilia
GPI consulting identified drivers to mitigate global price and revenue erosion based on tender strategy, market context and competitor landscape within hemophilia.
September 14, 2021
Identifying the relative clinical positioning in core EU markets
Using our award-winning, robust market access data we identified the relative clinical positioning in core EU markets while defining realistic value-based price estimations within the ultra-orphan space.
July 26, 2021
Net price forecasting and launch optimisation for an IO asset on UK oncology indication expansion for top tier pharmaceutical
Leveraging our data and analytics platform and proprietary methodology we provided a large pharmaceutical company with net price forecasting and launch optimisation for an IO asset.
June 16, 2021
GPI supports multinational biopharmaceutical company in forecasting their early-stage assets’ commercial opportunities
GPI supported a large biopharmaceutical company in forecasting their early-stage assets.
May 17, 2021
GPI developed price and product allocation strategy
GPI developed price and product allocation strategy
April 26, 2021